openPR Logo
Press release

Gynecological Cancer Drugs Market Report Explores and Analyses Essential Factors of Market Depending On Industry Situations, Market Needs, Business Strategies and Growth Condition

01-17-2019 09:08 AM CET | Health & Medicine

Press release from: Allied Market Research

Gynecological Cancer Drugs Market

Gynecological Cancer Drugs Market

Manufacturers' interest in hormone therapy and target treatment for gynecological cancer treatment is expected to have a significant impact on market growth during the forecast period.

The Gynecological Cancer Drugs Market is expected to grow at an average annual rate of 8.1% from 2017 to 2023 by 2023 to $ 1,617 million.

Cancer progresses when normal somatic cells become abnormal cells and continue to grow in an uncontrolled way. It has been named after the body part. Thus, gynecological cancer refers to a group of cancers that affect the female reproductive organs, such as the uterus, endometrium, ovaries, peritoneum, tubal, vagina, muscles and tissues supporting the vulva, cervix and uterus.

Growth in the global gynecological and cancer treatment market is driven by public agencies and private organizations to increase gynecological and cancer incidence, increase the importance of targeted drug therapy, increase government investment, and develop new drugs for cancer treatment. Increased risk factors leading to cancer. However, market growth is hampered by the high cost of drug development, the failure of anticancer therapy and the threat of side effects. On the contrary, advances in cancer drug research and the emergence of personalized medical approaches are expected to provide numerous opportunities for market growth during the forecast period.

Download PDF Report Sample @https://www.alliedmarketresearch.com/request-sample/3411?utm_source=sy

The list of key players profiled in this report include
• Apotex Inc.
• AstraZeneca Plc
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

The cervical cancer segment is expected to maintain its dominant position during the analysis period, owing to increase in prevalence of cervical cancer globally.
Targeted therapy segment is expected to grow rapidly, registering a CAGR of 8.9% throughout the forecast period, owing to increased benefits of targeted therapy over chemotherapy.

Buy Now (Data Pack Available with Discounted Price): @ https://www.alliedmarketresearch.com/checkout/682498?utm_source=sy

Key Findings of Gynecological Cancer Drugs Market:
• The chemotherapy segment accounted for nearly two-thirds share of the global market in 2016.
• Cervical cancer segment accounted for more than two-fifths share of the market in 2016.
• The ovarian cancer segment is expected to grow at the fastest CAGR of 10.0% from 2016 to 2022.
• Asia-Pacific is expected to be the fastest growing region, registering a CAGR of 9.8% during the forecast period.

North America accounted for more than one-third share of the global market in 2016, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in cancer incidence, growth in geriatric population, rise in patient awareness about the availability of treatment options, and favorable reimbursement framework for cancer drugs in the region. In addition, high adoption rate of cancer drugs and presence of highly sophisticated healthcare infrastructure are expected to present new growth opportunities to the players in this market.

Access Full Summery @ https://www.alliedmarketresearch.com/gynecological-cancers-drugs-market?utm_source=sy

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gynecological Cancer Drugs Market Report Explores and Analyses Essential Factors of Market Depending On Industry Situations, Market Needs, Business Strategies and Growth Condition here

News-ID: 1506740 • Views:

More Releases from Allied Market Research

Automotive Over-the-Air (OTA) Market Growth Expected to Reach US$ 13.71 billion by 2030
Automotive Over-the-Air (OTA) Market Growth Expected to Reach US$ 13.71 billion …
The global 𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐎𝐯𝐞𝐫-𝐭𝐡𝐞-𝐀𝐢𝐫 (𝐎𝐓𝐀) 𝐌𝐚𝐫𝐤𝐞𝐭 was valued at $2.59 billion in 2020, and is projected to reach $13.71 billion by 2030, registering a CAGR of 18.1% from 2021 to 2030. The 𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐎𝐯𝐞𝐫-𝐭𝐡𝐞-𝐀𝐢𝐫 (𝐎𝐓𝐀) 𝐌𝐚𝐫𝐤𝐞𝐭 is segmented on the basis of technology type, application, vehicle type, and region. By technology type, the global market is divided into firmware over-the-air, software over-the-air, by application, it is classified into telematics control
Drone Service Market Expanding at a Healthy 40.7% CAGR, To Reach a Value of $128.1853 Billion in 2030
Drone Service Market Expanding at a Healthy 40.7% CAGR, To Reach a Value of $128 …
According to a recent report published by Allied Market Research, titled, "Drone Service Market by Type, Duration of Service, Application, and Solution: Global Opportunity Analysis and Industry Forecast, 2021-2030," The global drone service market was valued at $4,215.8 Million in 2020, and is projected to reach $128,185.3 Million by 2030, registering a CAGR of 40.7% from 2021 to 2030. The research report offers quantitative and qualitative analyses of the overall
Spacecraft Market to Rise Up to the US$ 10.4 Billion by 2032, and to Grow at a CAGR of 5.9%
Spacecraft Market to Rise Up to the US$ 10.4 Billion by 2032, and to Grow at a C …
Allied Market Research published a report, titled, "Spacecraft Market by Type (Manned Spacecraft and Unmanned Spacecraft), and End Use (Commercial and Civil, and Military): Global Opportunity Analysis and Industry Forecast, 2022-2032". According to the report, the global spacecraft industry size generated $5.9 billion in 2022 and is anticipated to generate $10.4 billion by 2032, witnessing a CAGR of 5.9% from 2023 to 2032. The research report offers quantitative and qualitative
Hybrid Aircraft Market Valued $1.9 Billion in 2023, and is Estimated to reach $10.7 Billion by 2033
Hybrid Aircraft Market Valued $1.9 Billion in 2023, and is Estimated to reach $1 …
Allied Market Research published a report, titled, "Hybrid Aircraft Market by Aircraft Type (Regional Transport Aircraft, Business Jets and Light Aircrafts, and UAVs and AAM), Lift Technology (Conventional Takeoff and Landing, Short Takeoff and Landing, a Vertical Takeoff and Landing), and Mode of Operation (Piloted and Autonomous): Global Opportunity Analysis and Industry Forecast, 2025-2035". According to the report, the global hybrid aircraft industry size is expected to generate $1.9 billion

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top